missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SLAMF9 Monoclonal Antibody (330003)

Rat Monoclonal Antibody
Brand: Invitrogen™ MA561209
This item is not returnable.
View return policy
Description
Reconstitute at 0.5 mg/mL in sterile PBS.
The SLAM (signalling lymphocyte activation molecule) family is a novel group of receptors on T cells in modulating the immune response. SLAMF9, also known as CD2F-10 or CD84 homolog, is a 289 amino acid type I transmembrane protein that shares 58% identity with the mouse protein. The SLAMF9 protein is predominantly expressed in hematopoietic tissues and contains an extracellular region with only two N-linked glycosylation sites, a 20-residue transmembrane region and a highly positively charged 30-residue cytoplasmic tail, suggesting a role for SLAMF9 as an adhesion molecule. SLAMF9 is thought to function in the immune response as a coreceptor for lymphocyte activation.
Specifications
| SLAMF9 | |
| Monoclonal | |
| 0.5 mg/mL | |
| PBS with trehalose and no preservative | |
| Q9D780 | |
| SLAMF9 | |
| Mouse myeloma cell line NS0-derived recombinant mouse CD2F-10/SLAMF9, Phe18-Leu230. | |
| 100 μg | |
| Primary | |
| Mouse | |
| Antibody | |
| IgG2a |
| Western Blot | |
| 330003 | |
| Unconjugated | |
| SLAMF9 | |
| 2310026I04Rik; AI462096; CD2 antigen family, member 10; CD2 family member 10; CD2F10; CD2F-10; CD84 homolog 1; CD84H1; CD84-H1; cluster of differentiation 2 antigen family member 10; cluster of differentiation 84 homolog 1; RP11-48O20.3; SF2001; signaling lymphocytic activation molecule family member 2001; signaling lymphocytic activation molecule family member 9; SLAM family member 9; SLAMF9; UNQ1938/PRO4421 | |
| Rat | |
| Protein A/G | |
| RUO | |
| 98365 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction